Ambea ABCHIX:AMBEAS 82 3-Year ROIIC % is 10.96 as of Dec. 2025, which is 94% above its 10-year median of 5.65. GuruFocus rates CHIX:AMBEAS with a GF Score™ of 82/100 and a GF Value™ of kr110.38 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 620 Healthcare Providers & Services companies, Ambea AB ranks better than 64.19% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Ambea AB's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 10.96%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Ambea AB's 3-Year ROIIC % or its related term are showing as below:
CHIX:AMBEAs's 3-Year ROIIC % is ranked better than 64.19% of 620
companies
in the Healthcare Providers & Services industry
Industry Median: 3.28
vs CHIX:AMBEAs: 10.96
Ambea AB (CHIX:AMBEAs) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Ambea AB 3-Year ROIIC % Related Terms
Ambea AB 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Ambea AB's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:AMBEAS vs HCA, THC, DVA: 3-Year ROIIC % Comparison
For the Medical Care Facilities subindustry, Ambea AB's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ambea AB 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ambea AB's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Ambea AB's 3-Year ROIIC % falls into.
Ambea AB's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 1052.912 (Dec. 2025) - 640.0899 (Dec. 2022) )
/
( 22448 (Dec. 2025) - 18680 (Dec. 2022) )
=
412.8221
/
3768
=
10.96%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Ambea AB (CHIX:AMBEAS) has a 3-Year ROIIC % of 10.96 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Ambea AB and its competitors. This is 94% above median its historical median of 5.65. Over the past decade, Ambea AB's 3-Year ROIIC % has ranged from 1.27 to 37.11. According to the industry distribution chart, Ambea AB ranks #222 out of 620 companies in the Healthcare Providers & Services industry, placing it in the top 35.8%.
Is Ambea AB's 3-Year ROIIC % too high?
Ambea AB's current 3-Year ROIIC % of 10.96 is 94% above median its 10-year median of 5.65. Over the past 10 years, this metric has ranged from a low of 1.27 to a high of 37.11. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.28. Ambea AB's value of 10.96 is 234.1% above this industry median. Based on the distribution chart, Ambea AB ranks #222 out of 620 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Ambea AB has a GF Score™ of 82/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ambea AB's 3-Year ROIIC % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ambea AB ranks #222 out of 620 companies for 3-Year ROIIC %. This puts Ambea AB in the upper half of its industry. The industry median 3-Year ROIIC % is 3.28. Ambea AB's value of 10.96 is 234.1% above this benchmark. Historically, Ambea AB's own 3-Year ROIIC % has ranged from 1.27 to 37.11 over the past decade. While the company's 10-year median is 5.65 vs. the industry median of 3.28, Ambea AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.28, based on 620 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ambea AB's current 3-Year ROIIC % of 10.96 is 234.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Ambea AB and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ambea AB's current 3-Year ROIIC % is 10.96, which is 94% above median its own 10-year median of 5.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambea AB stock overvalued right now?
Based on GuruFocus' analysis, Ambea AB (CHIX:AMBEAS) is currently considered Significantly Overvalued. The stock's GF Value™ is kr110.38, compared to a current price of kr153.95 — trading 39.5% above its estimated fair value. The current 3-Year ROIIC % is 10.96, which is 94% above median its 10-year median of 5.65 and 234.1% above the Healthcare Providers & Services industry median of 3.28. Ambea AB's overall GF Score™ is 82/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Ambea AB (CHIX:AMBEAS), the current 3-Year ROIIC % is 10.96 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ambea AB (CHIX:AMBEAS) Overvalued in 2026?
Based on GuruFocus' analysis, Ambea AB stock appears to be overvalued.
The current stock price of kr153.95 is trading 39.5% above its estimated GF Value™ of kr110.38.
GuruFocus considers Ambea AB to be Significantly Overvalued.
Key valuation signals for CHIX:AMBEAS:
3-Year ROIIC %: 10.96 (94% above median its 10-year median of 5.65)
GF Value™: kr110.38 vs. price of kr153.95 (39.5% above fair value)
Industry Position: 234.1% above the Healthcare Providers & Services median (#222 of 620)
No single metric tells the full story. See the CHIX:AMBEAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ambea AB is a Swedish care-provider group focused on elderly care, disability care, psychosocial support, housing, staffing, and training across the Nordic region. The company's segment includes: i) Nytida: Comprises social care services for children, youth and adults, in Sweden, ii) Vardaga: Comprises nursing homes and home care in Sweden, iii) Stendi: Comprises social care for children, youth and adult in Norway, iv) Validia: Comprises social care for children, v) Altiden: Comprises social care for children, youth and adults as well as elderly care in Denmark, and vi) Klara: Comprises competence and staffing solutions for elderly and social care, and student health services in Sweden. The majority of the company's revenue is derived from the Vardaga segment.
82GF Score
Get the complete analysis for CHIX:AMBEAS
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AMBEAS has been successfully added to your 
